Boston Scientific Corp. <BSX.N>: Oppenheimer cuts target price to $85 from $90
BSX•Related News
NewtekOne schedules Q2 2026 earnings release, conference call
NEWT•
Mobile-Health Network Solutions, Jospong form joint venture with exclusive rights to deploy digital healthcare ecosystem in Ghana
MNDR•
Nasdaq trade halt continues <QMMM.O> reason not available at 09:31 AM
QMMM•
Sarepta gains after appointing former AbbVie executive Severino as CEO
SRPT•
Barings CEO Mike Freno says firm wins $2.1 billion NCIA mandate
MCI•